What Kinds of Breast Cancer Does Ibrance Treat? Breast cancer that is hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative and is advanced or has spread to other ...
The addition of Ibrance to endocrine therapy was not associated with preventing disease recurrence in patients with hormone receptor (HR)–positive, human epidermal growth factor receptor 2 ...
Preliminary study results examining the bispecific antibody, CDK4/6 inhibitor and hormone therapy combination in patients with advanced breast cancer were presented at SABCS. Treatment with bispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback